Bentham Science Logo

Track Your Manuscript:


Current Neuropharmacology

Volume 18, 12 Issues, 2020
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Open Access Articles



Synaptic Elimination in Neurological Disorders

, 2019; 17(11): 1071 - 1095

Pablo L. Cardozo, Izabella B. Q. de Lima, Esther M.A. Maciel, Nathália C. Silva, Tomas Dobransky and Fabíola M. Ribeiro*




Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?

, 2019; 17(11): 1004 - 1020

Estefania Gastaldello Moreira*, Karine Maria Boll, Dalmo Guilherme Correia, Janaina Favaro Soares, Camila Rigobello and Michael Maes









Relevance of CYP2C9 Function in Valproate Therapy

, 2019; 17(1): 99 - 106

Katalin Monostory*, Andrea Nagy, Katalin Tóth, Tamás Bűdi , Ádám Kiss, Máté Déri and Gábor Csukly













cGMP Signaling, Phosphodiesterases and Major Depressive Disorder

, 2011; 9(4): 715 - 727

Gillian W. Reierson, Shuyu Guo, Claudio Mastronardi, Julio Licinio and Ma-Li Wong





Editor-in-Chief

F. Nicoletti
University Rome"da Sapienza"
Rome
(Italy)
View Full Editorial Board

COPE Compliant

Journal History

Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
Scopus CiteScore Metrics: 4.72

New eBook

Neurobiology of Mood Disorders



You can view the contents of this eBook [here] or purchase it [here].

Advertisement

New Year Offer 2021Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog